Cardiol Therapeutics (CRDL) Interest Coverage Ratio (2021 - 2022)
Cardiol Therapeutics (CRDL) posted Interest Coverage Ratio of 59.88 for Q4 2022, down 17.8% on a QoQ basis from 50.83 in Q4 2021, and down 17.8% year-over-year from 72.84 in Q4 2021.
Cardiol Therapeutics (CRDL) Interest Coverage Ratio (2021 - 2022) Analysis & Trends
Cardiol Therapeutics' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 59.88 for Q4 2022.
- Quarterly Interest Coverage Ratio fell 17.8% year-over-year to 59.88 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 284.22 (down 88.73% YoY) and the FY2022 annual result came in at 272.13, down 81.36% from the prior year.
- Interest Coverage Ratio was 59.88 for Q4 2022 at Cardiol Therapeutics, down from 50.83 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 50.83 in Q4 2021 and bottomed at 59.88 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -59.88 |
| Dec 31, 2021 | -50.83 |